PARDP

 
Preferred Stock - Convertible Exchangeable Series 1 $2.4375 Dark or Defunct
Pink No Information
Contact Info
  • 300 Elliott Avenue West
  • Suite 530
  • Seattle, WA 98119

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Apr 02, 2012
Audited Financials Audited
Latest Report Sep 30, 2011 10-Q
CIK 0000755806
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: WA, USA
Year of Inc. 1984
Employees Not Available
Company Officers/Contacts
Michael A. Jackson Interim CFO
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm
Ernst & Young LLP
5 Times Square
New York, NY, 10036-6530
United States
 
Securities Counsel
Perkins Coie, LLP
1620 - 26th Street
South Tower
Santa Monica, CA, 90404-4013
United States
 
Investor Relations Firm
Argot Partners
200 Park Avenue South
Suite 1515
New York, NY, 10003
United States
 
Company History
  • Formerly=NeoRx Corp. until 6-06
PARDP Security Details Other Company Securities
Share Structure
Market Value1 $47,261 a/o Oct 23, 2017
Authorized Shares 1,120,000 a/o Dec 31, 2011
Outstanding Shares 78,768 a/o Dec 31, 2011
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 9,373 (0%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security